Browse > Article

The effect of periodontal therapy on the gingival thickness in patients with drug-induced gingival enlargement  

Kim, Won-Kyung (Department of Dentistry, College of Medicine, University of Ulsan.)
Baek, Jin (Department of Dentistry, Asan Medical Center)
Lee, Young-Kyoo (Department of Dentistry, College of Medicine, University of Ulsan.)
Publication Information
Journal of Periodontal and Implant Science / v.35, no.4, 2005 , pp. 1109-1116 More about this Journal
Abstract
The purpose of this study was to observe the effects of periodontal therapy, including nonsurgical periodontal therapy with azithromycin, surgical therapy, and maintenace therapy on the drug-induced gingival enlargement, by means of measuring gingival thickness. The test group of 18 patients with drug-induced gingival enlargement received scaling, root planing with azithromycin for 5 days, with or without surgical periodontal treatment. The control group of 18 patients who had not taken any medication, received scaling and root planing, with or without surgical periodontal treatment. Both groups received supportive periodontal therapy every 3 months for 2 years. The mean period of total treatment is 32 months in the test group and 31 months in the control group. The thickness of the buccal gingiva was measured using an ultrasonic device of $SDM^{(R)}$(Krupp Corp., Essen, Germany). The results revealed that the test $group(1.21{\pm}0.51mm)$ showed statistically thicker buccal gingiva than the control $group(1.01{\pm}0.3mm)$. In the test group, the buccal gingiva was thickest on 2nd molars and was thinnest on canines of both dental arches. In the control group, the buccal gingiva was thickest on central incisors in the maxilla and 2nd molars in the mandible, while the thinnest areas were on canines in the maxilla and 1st premolars in the mandible. It would be concluded that the periodontal treatment with azithromycin aids in decreasing the degree of the gingival enlargement but cannot prevent the recurrence completely.
Keywords
Drug-induced gingival enlargement; Gingival thickness;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Camargo PM. Melnick PR. Pirih FQ. Lagos R & Takei HH. Treatment of drug-induced gingival enlargement: Aesthetic and functional considerations. Periodontology 2000 2001; 27: 131-138   DOI   ScienceOn
2 Kantarci A, Cebeci I, Tuncer O, et al. Clinical effects of periodontal therapy on the severity of cyclosporin A-inducedbgingival hyperplasia. J Periodontol 1999: 70:587-593   DOI   PUBMED
3 Hancock RH, Swan RH. Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque. J Clin Periodontol 1992:19:12-14   DOI   ScienceOn
4 Hall WE. Dilantin hyperplasia: a preventable lesion. J Periodontal Res 1969; 4:36-37   DOI   PUBMED
5 강철흔, 장문택, 류성훈, 김형섭 : '한국 성인의 각화치은 두께측정에 관한 연구', 대한치주과학회지, 제30권(1호): 179-185, 2000
6 Ellis JS, Seymour RA, Steele JG, et al. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999: 70: 63-67   DOI   ScienceOn
7 Boltchi FE. Rees TD. Iacopino AM. Cyclosporine A-induced gingival overgrowth: A comprehensive review. Quintessence Int 1999;30:775-783   PUBMED
8 Darbar UR, Hopper C, Speight PM, Neman HN. Combined treatment approach to gingival overgrowth due to drug therapy. J Clin Periodontol 1996: 23: 941-944   DOI   ScienceOn
9 Somacarrera ML, Lucas M. Schully C, Barrios C. Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients. Br Dent J 1997: 183:89-94   DOI   PUBMED   ScienceOn
10 조형호, 이영규. 장기이식환자에서의 치은비대에 관한 Azithromycin의 효과. 대한치주과학회지 1998: 28: 829-836   DOI
11 Ikawa K. Ikawa M. Shimauchi H. et al. Treatment of gingival overgrowth induced by Manidipine Adiministration. A Case Report J Periodontol 2002: 73: 115-122   DOI   PUBMED   ScienceOn
12 Academy Report. Drug-Associated gingival enlargement. J Periodontol 2004; 75 : 1424-1431   DOI   PUBMED   ScienceOn
13 Pilloni A, Camargo PM, Carere M, Carraza Jr. FA. Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: Gingivectomy versus periodontal flap. J Periodontol 1998: 69:791-797   DOI   PUBMED   ScienceOn
14 Jones JE. Weddell JA McKnown CG. Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population. J Oral Maxillofac Surg 1988; 46: 385-390   DOI   ScienceOn
15 Kimball OP. The treatment of epilepsy with sodium diphenyl hydantoinate. JAMA 1939:112:1244-1245   DOI
16 김성준, 김태일, 설양조 등. 치은두께와 임상검사 지수들과의 상관관계. 대한치주과학회지 2005: 35:537-548
17 Barclay S. Thomason JM. Idle JR. Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992; 19:311-314   DOI   PUBMED
18 Fattor L. Stablein M. Bredfeldt G et al. Gingival hyperplasia: A side effect of nifedipine and diltiazem. Spec Care Dent 1991: 11: 107-109   DOI   ScienceOn
19 McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivla scores, and cyclosporin. Oral Surg Oral Med Oral Pathol. 1987:64:293-297   DOI   ScienceOn
20 Goaslind GD, Robertson PB, Mahan CJ, Morrison WW, Olson JV. Thickness of facial gingiva. J Periodontol 1977:48: 768-771   DOI   PUBMED
21 Eger T, Muller HP, Heinecke A. Ultrasonic determination of gingival thickness. Subject variation and influence of tooth type and clinical features. J clin peirodontol 1996; 23: 839-845   DOI   ScienceOn
22 Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998:65:1611-1615   DOI   ScienceOn
23 Gomez E, Sanchez-Nunez M. Sanchez JE, et al. Treatment of cyclosporininduced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997: 12: 2694-2697.   DOI   ScienceOn
24 Hallmon WW, Rossmann JA, The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontology 2000 1999: 21: 176-196   DOI   ScienceOn
25 Kydd WL, Daly CH, Wheeler JB III. The thickness measurement of masticatory mucosa in vivio. International Dental Journal 1971:21:430-441   PUBMED
26 Ilgenli T, Atilla G, Baylas H. Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results. J Periodontol 1999:70:967-972   DOI   PUBMED
27 Vandana KL, Savitha B. Thickness of gingiva in association with age, gender and dental arch location. J Clin Periodontol 2005; 32: 828-830   DOI   ScienceOn
28 Müller HP, Schaller N, Heinecke A. Thickness of masticatorz mucosa. J Clin Periodontol 2000:27:431-436   DOI   ScienceOn
29 Nishikawa S, Nagata T, Morisaki I, et al. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J Periodontol 1996: 67: 463-471   DOI   PUBMED   ScienceOn
30 Seymour RA , Smith DG. The effect of a plaque control program on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991: 18; 107-110   DOI   PUBMED
31 Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996: 23: 165-175   DOI   ScienceOn